Jennifer Leigh-stewar Ghand

Array ( [id] => 6095232 [patent_doc_number] => 20020051767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'CANCER TREATMENT' [patent_app_type] => new [patent_app_number] => 08/527373 [patent_app_country] => US [patent_app_date] => 1995-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7551 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20020051767.pdf [firstpage_image] =>[orig_patent_app_number] => 08527373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4291191 [patent_doc_number] => 06268546 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Ovary-tissue transcriptional factors' [patent_app_type] => 1 [patent_app_number] => 8/487087 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 15215 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268546.pdf [firstpage_image] =>[orig_patent_app_number] => 487087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3823761 [patent_doc_number] => 05731182 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-24 [patent_title] => 'Non-mammalian DNA virus to express an exogenous gene in a mammalian cell' [patent_app_type] => 1 [patent_app_number] => 8/486341 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 15037 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/731/05731182.pdf [firstpage_image] =>[orig_patent_app_number] => 486341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3937330 [patent_doc_number] => 05871986 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Use of a baculovirus to express and exogenous gene in a mammalian cell' [patent_app_type] => 1 [patent_app_number] => 8/311157 [patent_app_country] => US [patent_app_date] => 1994-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 5330 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/871/05871986.pdf [firstpage_image] =>[orig_patent_app_number] => 311157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1154246 [patent_doc_number] => 06761884 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-13 [patent_title] => 'Vectors including foreign genes and negative selective markers' [patent_app_type] => B1 [patent_app_number] => 08/289832 [patent_app_country] => US [patent_app_date] => 1994-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 5365 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/761/06761884.pdf [firstpage_image] =>[orig_patent_app_number] => 08289832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1278571 [patent_doc_number] => 06645942 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-11 [patent_title] => 'Somatic cell gene therapy' [patent_app_type] => B1 [patent_app_number] => 08/232452 [patent_app_country] => US [patent_app_date] => 1994-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11017 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/645/06645942.pdf [firstpage_image] =>[orig_patent_app_number] => 08232452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1570463 [patent_doc_number] => 06498147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-24 [patent_title] => 'Suppression of nuclear factor-b dependent processes using oligonucleotides' [patent_app_type] => B2 [patent_app_number] => 08/110161 [patent_app_country] => US [patent_app_date] => 1993-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 8876 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/498/06498147.pdf [firstpage_image] =>[orig_patent_app_number] => 08110161 [rel_patent_id] =>[rel_patent_doc_number] =>)